North Capital, Inc. Charles River Laboratories International, Inc. Transaction History
North Capital, Inc.
- $129 Billion
- Q3 2025
A detailed history of North Capital, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, North Capital, Inc. holds 1 shares of CRL stock, worth $180. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$180% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
637Shares Held
52.8MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.05 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$916 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$678 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.18MShares$392 Million0.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$335 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.16B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...